Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic to Share Melbourne Research Data With Ventana Medical Systems

NEW YORK (GenomeWeb) – Transgenomic announced today that it has signed a data sharing agreement with Ventana Medical Systems, allowing Ventana access to results from research conducted under a separate agreement and collaboration between Transgenomic and the University of Melbourne.

Melbourne investigators have been performing clinical validation studies using Transgenomic’s Multiplexed ICE COLD-PCR (MX-ICP) technology. Researchers tested cancer patient DNA samples with both MX-ICP and next-generation sequencing in order to identify and characterize ultra-low frequency mutations that are detectable by the PCR method but not by NGS.

Prompted by that research collaboration, Transgenomic granted the University of Melbourne its own license for ICE COLD-PCR, with exclusive rights to MX-ICP-enabled EGFR liquid biopsy cancer assays in Australia. The partners also agreed to jointly provide biomarker identification services to biopharmaceutical companies.

Transgenomic President and CEO Paul Kinnon said in a statement that the company believes that results of the Melbourne research could "significantly contribute to knowledge about the genetics of patient response to targeted cancer therapies." He added that the firm welcomes Ventana's interest in accessing this data as an "acknowledgement of the high quality and value characterizing this DNA analysis."

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.